Atherosclerotic Complex coronary Artery Diseases treated by Zotarolimus-Eluting Resolute Onyx stent ~A multi-center registry~

Atherosclerotic Complex coronary Artery Diseases treated by Zotarolimus-Eluting Resolute Onyx stent ~A multi-center registry~ - ARCADIA ZERO

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038451

Enrollment

800

Registered

2019-10-31

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic complex coronary artery diseases

Interventions

None listed

Sponsors

Toyohashi Heart Center

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Incidence of target lesion failure (TLF) within 12 months after Onyx coronary stenting.	—

Countries

Japan

Contacts

Public ContactKeiji Akashi

CV Quest Co.,Ltd Clinical Research Support

arcadia@cvq.co.jp03-6427-9947

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026